Cardiovascular Safety, Long‐Term Noncardiovascular Safety, and Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systemic Review and Meta‐Analysis With Trial Sequential Analysis - Zhang, Xin‐Lin; Zhu, Qing‐Qing; Chen, Yu‐Han; Li, Xue‐Ling; Chen, Fu; Huang, Jian‐An; Xu, Biao (Journal of the American Heart Association, 2018)
Keywords: cardiovascular disease; Cardiovascular Diseases - epidemiology; Cardiovascular Diseases - prevention & control; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - epidemiology; Diabetes Mellitus, Type 2 - metabolism; Diabetic Nephropathies - epidemiology; Diabetic Nephropathies - prevention & control; Female; Humans; Kidney - drug effects; Kidney - metabolism; Male; meta‐analysis; Middle Aged; Observational Studies as Topic; observational study; Patient Safety; Protective Factors; randomized controlled trial; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; SGLT2 (sodium–glucose cotransporter 2) inhibitor; Sodium-Glucose Transporter 2 - drug effects; Sodium-Glucose Transporter 2 - metabolism; Sodium-Glucose Transporter 2 Inhibitors - adverse effects; Sodium-Glucose Transporter 2 Inhibitors - therapeutic use; Systematic Review and Meta‐Analysis; Time Factors; Treatment Outcome; trial sequential analysis; cardiovascular disease; trial sequential analysis; meta‐analysis; SGLT2 (sodium–glucose cotransporter 2) inhibitor; observational study; randomized controlled trial